FDA Bolsters Rules On Outside Advisors
Amid criticism of conflicts of interest in its advisory committee processes, the Food and Drug Administration said Monday it plans to develop guidelines to ensure that outside experts who provide scientific...To view the full article, register now.
Already a subscriber? Click here to view full article